Loading the session
Loading the session
Loading instrument
$360.17
+1.77%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 15:08 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: +14.7% (SPY −2.6%, XLV +9.9%). 3 months: +13.3% (SPY −2.2%, XLV +13.5%). 1 year: +37.3% (SPY +10.4%, XLV +27.4%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: LH, SPY and XLV · as of 3 Nov 2026
Closed at $353.92 on 3 Nov 2026: 4.6% below the 52-week high of $371.00 (28 Oct 2026) and 44.7% above the low of $244.52 (7 Nov 2025).
Daily price bars, split-adjusted · as of 3 Nov 2026
28 Oct 2026 volume of 1.8M shares was 2.4× the average of the 30 sessions before it (736.2K), as the price rose 8.8%. SPY traded 0.7× its own average that session.
Daily volume against a 30-session baseline · as of 28 Oct 2026
The 3 Nov 2026 close of $353.92 was 9.3% above its 50-day average ($323.90) and 22.7% above its 200-day average ($288.40). It has closed above the 200-day for 91 sessions, since 26 Jun 2026. The 50-day average crossed above the 200-day on 23 Jul 2026, 72 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
$0.72 a share, payable 11 Dec 2026; unchanged from the previous payment (ex-date 28 Aug 2026).
Corporate actions record · as of 4 Nov 2026
Price return, split-adjusted
At the 3 Nov 2026 close
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
October 28, 2026
+8.78%July 24, 2025
+6.86%August 1, 2024
+8.33%